Publications

5600 Results

When offered to participate: A systematic review and meta-analysis of patient agreement to participate in cancer clinical trials

Authors
J Unger;D Hershman;C Till;L Minasian;R Osarogiagbon;M Fleury;R Vaidya
Journal / Conference
Journal of the National Cancer Institute Mar 1;113(3):244-257. doi: 10.1093/jnci/djaa155.
Year
2021
Research Committee(s)
Cancer Care Delivery
PMID
PMID33022716
PMC
PMC7936064

An Intergroup Approach for Advanced Stage Classical Hodgkin Lymphoma (cHL) in Adolescents and Young Adults (AYA): SWOG S1826

Authors
S Castellino;M Leblanc;A Herrera;S Parsons;A Punnett;D Hodgson;S Rutherford;N Kahn;L Constine;K Davidson;A Prica;JW Friedberg;K Kelly
Journal / Conference
INTERNATIONAL SYMPOSIUM ON CHILDHOOD, ADOLESCENT AND YOUNG ADULT HODGKIN LYMPHOMA (ISCAYAHL) (5/13-16/20, Berlin, Germany)
Year
2021
Research Committee(s)
Lymphoma
Study Number(s)
S1826

Genomic analysis of germline variation associated with survival of colorectal cancer patients treated with chemotherapy plus biologics in CALGB/SWOG 80405 (Alliance)

Authors
F Innocenti;A Sibley;S Patil;A Etheridge;C Jiang;F-S Ou;S Denning;G Casey;M Bertagnolli;H McLeod;T Auman;CD Blanke;Y Furukawa;A Venook;M Kubo;H-J Lenz;J Parker;M Ratain;K Owzar
Journal / Conference
Clinical Cancer Research Jan 1;27(1):267-275
Year
2021
Research Committee(s)
Gastrointestinal
PMID
PMID32958699
PMC
PMC7785628
Study Number(s)
CTSU/C80405

A Phase II Study of Telisotuzumab Vedotin (Teliso-V, Abbv-399) in Patients with C-Met Positive Stage I or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-Study SWOG S1400K, NCT03574753)

Authors
S Waqar;M Redman;SM Arnold;FR Hirsch;PC Mack;LH Schwartz;D Gandara;T Stinchcombe;S Ramalingam;S Tanna;R Raddin;K Minichiello;K Kelly;JD Bradley;RS Herbst;V Papadimitrakopoulou
Journal / Conference
Clinical Lung Cancer May;22(3):170-177. doi: 10.1016/j.cllc.2020.09.013. Epub 2020 Oct 14.
Year
2021
Research Committee(s)
Lung
PMID
PMID33221175
PMC
PMC8044254
Study Number(s)
S1400K

SWOG S1400A (NCT #02154490): A phase II study of Durvalumab for previously treated patients with stage IV squamous cell lung cancer (Lung-MAP sub-study)

Authors
H Borghaei;M Redman;K Kelly;S Waqar;F Robert;G Kiefer;P Stella;K Minichiello;D Gandara;RS Herbst;V Papadimitrakopoulou
Journal / Conference
Clinical Lung Cancer May;22(3):178-186. doi: 10.1016/j.cllc.2020.10.015. Epub 2020 Nov 10.
Year
2021
Research Committee(s)
Lung
PMID
PMID33358401
PMC
PMC8686189
Study Number(s)
S1400A

Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG S1406)

Authors
S Kopetz;K Guthrie;V Morris;H-J Lenz;A Magliocco;D Maru;S Airhart;Y Yan;R Lanman;G Manyam;D Hong;A Sorokin;C Atreya;C Allegra;K Raghav;S Wang;C Lieu;S McDonough;P Philip;H Hochster
Journal / Conference
Journal of Clinical Oncology Feb 1;39(4):285-294
Year
2021
Research Committee(s)
Gastrointestinal
PMID
PMID33356422
PMC
PMC8462593
Study Number(s)
S1406

Bortezomib, Lenalidomide, Dexamethasone with or without Elotuzumab for Untreated, High-Risk Myeloma – Primary Analysis of the SWOG-1211 Randomized Phase II Trial

Authors
S Usmani;A Hoering;S Ailawadhi;R Sexton;B Lipe;S Hita;J Valent;M Rosenzweig;J Zonder;M Dhodapkar;N Callander;T Zimmerman;P Voorhees;B Durie;V Rajkumar;P Richardson;R Orlowski
Journal / Conference
Lancet Haematology Jan;8(1):e45-e54. doi: 10.1016/S2352-3026(20)30354-9. Epub 2020 Dec 22
Year
2021
Research Committee(s)
Myeloma
PMID
PMID33357482
Study Number(s)
S1211

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

Authors
D Conti;B Darst;EJ Saunders;X Sheng;A Chou;F Schumacher;D Albanes;C Tangen;P Goodman;IM Thompson;EA Klein;A Hsing;R Eeles;Z Kote-Jarai;C Haiman
Journal / Conference
Nature Genetics, Jan;53(1):65-75
Year
2021
Research Committee(s)
Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
PMID
PMID33398198
PMC
PMC8148035
Study Number(s)
S0000, SWOG-9217

Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With Cancer

Authors
C Van Poznak;J Unger;A Darke;C Moinpour;R Bagramian;M Schubert;L Hansen;J Floyd;S Dakhil;D Lew;J Wade;M Fisch;NL Henry;D Hershman;J Gralow
Journal / Conference
JAMA Oncology 2021 Feb 1;7(2):246-254. doi: 10.1001/jamaoncol.2020.6353; Dec 17;e206353. doi: 10.1001/jamaoncol.2020.6353. Online ahead of print
Year
2021
Research Committee(s)
Symptom Management and Survivorship
PMID
PMID33331905
PMC
PMC7747039
Study Number(s)
S0702

Identifying novel susceptibility genes for colorectal cancer risk from a transcriptome-wide association study of 125,478 subjects

Authors
X Guo;W Lin;W Wen;S Bien;C Qu;J Huyghe;G Abecasis;D Albanes;S Berndt;S Bezieu;DT Bishop;H Brenner;S Buch;A Burnett-Hartman;PT Campbell;S Castellvi Bel;AT Chan;J Chang-Claude;S Chanock;SH Cho;D Conti;A de la Chapelle;E Feskens;S Gallinger;G Giles;P Goodman;A Gsur;M Guinter;M Gunter;J Hampe;H Hampel;T Harrison;R Hayes;M Hoffmeister;MA Jenkins;E Kampman;HM Kang;T Keku;HR Kim;L Le Marchand;SC Lee;CI Lee;L Li;A Lindbom;RL Milne;V Moreno;P Newcomb;D Nickerson;K Offir;U Peters;P Pharaoh;E Platz;J Potter;G Rennert;L Sakoda;C Schafmayer;SL Schmitt;R Schoen;F Schumacher;M Slattery;YR Su;C Tangen;C Ulrich;F van Duijnhoven;B Van Guelpen;K Visvanathan;P Vodicka;L Vodickova;X Wang;E White;A Wolk;MO Woods;S Gruber;G Casey;L Hsu;W Zheng
Journal / Conference
Gastroenterology Mar;160(4):1164-1178.e6. doi: 10.1053/j.gastro.2020.08.062. Epub 2020 Oct 12.
Year
2021
Research Committee(s)
Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
PMID
PMID33058866
PMC
PMC7956223
Study Number(s)
S0000